ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $14,000 | -17.6% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $17,000 | +41.7% | 10,000 | 0.0% | 0.01% | +66.7% |
| Q4 2020 | $12,000 | -14.3% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q3 2020 | $14,000 | +16.7% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $12,000 | 0.0% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $12,000 | -42.9% | 10,000 | 0.0% | 0.01% | -14.3% |
| Q4 2019 | $21,000 | -4.5% | 10,000 | 0.0% | 0.01% | -30.0% |
| Q3 2019 | $22,000 | -12.0% | 10,000 | 0.0% | 0.01% | -9.1% |
| Q2 2019 | $25,000 | -28.6% | 10,000 | 0.0% | 0.01% | -26.7% |
| Q1 2019 | $35,000 | +52.2% | 10,000 | 0.0% | 0.02% | +36.4% |
| Q4 2018 | $23,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |